[
    "{\"step_by_step_thinking\": \"Based on the information provided in Document [0], LB-100 has been shown to sensitize ovarian carcinoma cells to cisplatin-mediated cell death. In vitro and in vivo studies have demonstrated that LB-100 sensitizes ovarian cancer cells to cisplatin by abrogating cell-cycle arrest induced by cisplatin and modulating the DNA-damage response pathway. Therefore, the answer is yes, LB-100 can sensitize ovarian carcinoma to cisplatin.\", \"answer_choice\": \"A\"}"
]